Perspective Therapeutics (CATX) Non-Current Deferred Tax Liability (2023 - 2026)

Perspective Therapeutics has disclosed Non-Current Deferred Tax Liability across 4 years of filings, most recently posting $1.7 million for Q1 2026.

• Non-Current Deferred Tax Liability for Q1 2026 came in at $1.7 million, down 31.78% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.7 million (down 31.78% YoY), and the FY2025 annual result was $1.7 million, down 31.78% from the prior year.
• Non-Current Deferred Tax Liability came in at $1.7 million for Q1 2026 at Perspective Therapeutics, roughly flat from $1.7 million in the prior quarter.
• In the past five years, Non-Current Deferred Tax Liability ranged from a high of $4.6 million in Q4 2023 to a low of $1.7 million in Q4 2025.
• The 4-year median for Non-Current Deferred Tax Liability is $2.5 million (2024), against an average of $3.2 million.
• Across the five-year window, Non-Current Deferred Tax Liability plunged 45.67% in 2024 and tumbled 31.78% in 2025, its largest moves.
• Perspective Therapeutics' Non-Current Deferred Tax Liability stood at $4.6 million in 2023, then slumped by 45.67% to $2.5 million in 2024, then slumped by 31.78% to $1.7 million in 2025, then changed by 0.0% to $1.7 million in 2026.
• The last three Non-Current Deferred Tax Liability figures came in at $1.7 million (Q1 2026), $1.7 million (Q4 2025), and $2.5 million (Q3 2025), per Business Quant data.